Cancer Nursing Today Announces Its Inaugural CARE Award
MANALAPAN, N.J. (PRWEB) May 16, 2023 — Nominations for the award, which recognizes an oncology nurse who provides important care for patients, are now open
MANALAPAN, N.J. (PRWEB) May 16, 2023 — Nominations for the award, which recognizes an oncology nurse who provides important care for patients, are now open
A recent prospective study examined the use of focal salvage reirradiation using external beam radiotherapy to determine its efficacy and feasibility.
Drs. Ambinder and Sonpavde provide an update for CheckMate 901, characterizing treatment benefit in responders.
A new study recorded data on the type of treatment received in each line of therapy for advanced urothelial carcinoma, as well as the attrition…
Drs. Thomas Zilli and Pierre Blanchard join The Uromigos at APCCC 2024 to debate the use of radiation therapy in prostate cancer and oligometastatic disease.
Drs. Murray and Broenimann highlight and evaluation of urinary genomic profiling for detection and molecular staging of UTUC.
A study to determine the potential utility of ADCs targeting TROP-2 in both localized PSCC and distant metastases.
Dr. Li highlights the significance of adverse pathologic features at radical prostatectomy for AS-eligible patients.
Enzalutamide and lutetium-177–labeled prostate-specific membrane antigen-617 have both been proven to improve OS rates in patients with mCRPC.
Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.
Brian and Tom speak with Drs. Piet Ost and Jason Efstathiou at ASCCC 2024 to discuss the data for and against the use of radiation…